5591 - 5600 of 8587 Results
Title
Year
-
OPENTitle: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 97Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.27158Best OA location URL: https://escholarship.org/content/qt5vs9p83m/qt5vs9p83m.pdfCitation Count: 4
-
OPENTitle: Personalised regional modelling predicts tau progression in the human brainJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 23Issue #: 7Start Page: e3003241End Page: e3003241Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3003241Best OA location URL: https://doi.org/10.1371/journal.pbio.3003241Citation Count: 0
-
OPENTitle: Neuronal α‐Synuclein Disease Stage Progression over 5 YearsJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 7Start Page: 1318End Page: 1330Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30191Citation Count: 2
-
OPENTitle: Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 1Start Page: 96End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25376Citation Count: 36
-
RESTRICTEDTitle: Thalamic deep brain stimulation for drug-induced tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 11Start Page: 1369End Page: 1370Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033Citation Count: 7
-
RESTRICTEDTitle: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00816-wBest OA location URL: https://www.nature.com/articles/s41531-024-00816-w.pdfCitation Count: 2
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 102
-
OPENTitle: Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01008-wCitation Count: 0
-
OPENTitle: Tissue specific LRRK2 interactomes reveal a distinct striatal functional unitJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 1Start Page: e1010847End Page: e1010847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1010847Best OA location URL: https://doi.org/10.1371/journal.pcbi.1010847Citation Count: 9
-
OPENTitle: White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 892End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.09.025Best OA location URL: https://doi.org/10.1016/j.nicl.2018.09.025Citation Count: 66